303 related articles for article (PubMed ID: 24259695)
1. Avanafil for erectile dysfunction.
Kyle JA; Brown DA; Hill JK
Ann Pharmacother; 2013 Oct; 47(10):1312-20. PubMed ID: 24259695
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial.
Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Moon KH; Chung WS; Min KS; Suh JK; Hyun JS; Park K; Park JK
BJU Int; 2012 Dec; 110(11):1801-6. PubMed ID: 22448738
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability.
Wang R; Burnett AL; Heller WH; Omori K; Kotera J; Kikkawa K; Yee S; Day WW; DiDonato K; Peterson CA
J Sex Med; 2012 Aug; 9(8):2122-9. PubMed ID: 22759639
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction.
Goldstein I; McCullough AR; Jones LA; Hellstrom WJ; Bowden CH; Didonato K; Trask B; Day WW
J Sex Med; 2012 Apr; 9(4):1122-33. PubMed ID: 22248153
[TBL] [Abstract][Full Text] [Related]
5. Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction.
Limin M; Johnsen N; Hellstrom WJ
Expert Opin Investig Drugs; 2010 Nov; 19(11):1427-37. PubMed ID: 20939743
[TBL] [Abstract][Full Text] [Related]
6. Avanafil for the treatment of erectile dysfunction.
Zurawin JL; Stewart CA; Anaissie JE; Yafi FA; Hellstrom WJ
Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1163-70. PubMed ID: 27416913
[TBL] [Abstract][Full Text] [Related]
7. Avanafil for the treatment of erectile dysfunction. An updated review.
Egui-Rojo MA; Moncada-Iribarren I; Carballido-RodrÃguez J; MartÃnez-Salamanca JI
Arch Esp Urol; 2014 Dec; 67(10):839-47. PubMed ID: 25582903
[TBL] [Abstract][Full Text] [Related]
8. An open-label, long-term evaluation of the safety, efficacy and tolerability of avanafil in male patients with mild to severe erectile dysfunction.
Belkoff LH; McCullough A; Goldstein I; Jones L; Bowden CH; DiDonato K; Trask B; Day WW
Int J Clin Pract; 2013 Apr; 67(4):333-41. PubMed ID: 23521325
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness and safety of avanafil for erectile dysfunction: a systematic review and meta-analysis.
Wang H; Yuan J; Hu X; Tao K; Liu J; Hu D
Curr Med Res Opin; 2014 Aug; 30(8):1565-71. PubMed ID: 24701971
[TBL] [Abstract][Full Text] [Related]
10. A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Therapeutic Confirmatory Study to Evaluate the Safety and Efficacy of Avanafil in Korean Patients with Erectile Dysfunction.
Park HJ; Kim SW; Kim JJ; Lee SW; Paick JS; Ahn TY; Park K; Park JK; Park NC
J Korean Med Sci; 2017 Jun; 32(6):1016-1023. PubMed ID: 28480661
[TBL] [Abstract][Full Text] [Related]
11. Avanafil - a further step to tailoring patient needs and expectations.
Boeri L; Capogrosso P; Ventimiglia E; Serino A; La Croce G; Russo A; Damiano R; Montorsi F; Salonia A
Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1171-81. PubMed ID: 27232892
[TBL] [Abstract][Full Text] [Related]
12. Avanafil: A comprehensive drug profile.
Al-Majed AA; AlKhairallah A; Attwa MW; Alkahtani HM; El-Azab AS; Abdel-Aziz AA; Alkhider A; Hassan SB; Bakheit AH
Profiles Drug Subst Excip Relat Methodol; 2024; 49():115-151. PubMed ID: 38423706
[TBL] [Abstract][Full Text] [Related]
13. Avanafil, a highly selective phosphodiesterase type 5 inhibitor for erectile dysfunction, shows good safety profiles for retinal function and hemodynamics in anesthetized dogs.
Mochida H; Yano K; Inoue H; Yee S; Noto T; Kikkawa K
J Urol; 2013 Aug; 190(2):799-806. PubMed ID: 23321580
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy.
Cui Y; Liu X; Shi L; Gao Z
Andrologia; 2016 Feb; 48(1):20-8. PubMed ID: 25684196
[TBL] [Abstract][Full Text] [Related]
15. A survey on the experience of 136 Italian urologists in the treatment of erectile dysfunction with PDE5 inhibitors and recommendations for the use of Avanafil in the clinical practice.
Mirone V; Fusco F; Parazzini F; Zucchi A
Arch Ital Urol Androl; 2016 Jul; 88(2):128-32. PubMed ID: 27377089
[TBL] [Abstract][Full Text] [Related]
16. Avanafil (Stendra)--another PDE5 inhibitor for erectile dysfunction.
Med Lett Drugs Ther; 2014 May; 56(1442):37-8. PubMed ID: 24818838
[No Abstract] [Full Text] [Related]
17. Future prospects in the treatment of erectile dysfunction: focus on avanafil.
Alwaal A; Al-Mannie R; Carrier S
Drug Des Devel Ther; 2011; 5():435-43. PubMed ID: 22087063
[TBL] [Abstract][Full Text] [Related]
18. Avanafil for the treatment of erectile dysfunction.
Segal R; Burnett AL
Drugs Today (Barc); 2012 Jan; 48(1):7-15. PubMed ID: 22384456
[TBL] [Abstract][Full Text] [Related]
19. Avanafil for male erectile dysfunction: a systematic review and meta-analysis.
Cui YS; Li N; Zong HT; Yan HL; Zhang Y
Asian J Androl; 2014; 16(3):472-7. PubMed ID: 24589460
[TBL] [Abstract][Full Text] [Related]
20. A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy.
Mulhall JP; Burnett AL; Wang R; McVary KT; Moul JW; Bowden CH; DiDonato K; Shih W; Day WW
J Urol; 2013 Jun; 189(6):2229-36. PubMed ID: 23219537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
